The human leucocyte antigen-G 14-basepair polymorphism correlates with graft-versus-host disease in unrelated bone marrow transplantation for thalassaemia

被引：44
作者：
La Nasa, Giorgio
Littera, Roberto
Locatelli, Franco
Lai, Sara
Alba, Francesco
Caocci, Giovanni
Lisini, Daniela
Nesci, Sonia
Vacca, Adriana
Piras, Eugenia
Bernardo, Maria Ester
Cesare-Merlone, Alessandra Di
Orru, Sandro
Carcassi, Carlo
机构：
[1] Univ Cagliari, Cattedra Genet Med, Osped R Binaghi, Dipartimento Sci Med Internist, I-09126 Cagliari, Italy
[2] Univ Cagliari, Dipartimento Sci Mediche Internistiche, Osped R Binaghi, Ctr Trapianti Midollo Osseo,Cattedra Ematol, Cagliari, Italy
[3] Osped R Binaghi, Ctr Res Trapianti, Cagliari, Italy
[4] Univ Pavia, Policlin San Matteo, Fonaz IRCCS, I-27100 Pavia, Italy
[5] Osped S Salvatore, Ctr Trapianti Midollo Osseo Muraglia, Unita Operat Ematol, Pesaro, Italy
来源：
BRITISH JOURNAL OF HAEMATOLOGY | 2007年 / 139卷 / 02期
关键词：
human leucocyte antigen-G; 14-basepair polymorphism; acute graft-versus-host disease; thalassaemia; bone marrow transplantation;
D O I：
10.1111/j.1365-2141.2007.06779.x
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
The presence of the 14-bp insertion polymorphism of the human leucocyte antigen (HLA)-G gene (HLA-G) promotes immune tolerance through increased synthesis of HLA-G molecules. We investigated this polymorphism in a large cohort of 53 thalassaemia patients transplanted from an unrelated donor. Sixteen patients (30.2%) homozygous for the 14-bp deletion had a higher risk of developing acute graft-versus-host disease (aGvHD) than patients homozygous for the 14-bp insertion (-14-bp/-14-bp vs +14-bp/+14-bp: Relative Risk = 15.0; 95% confidence interval 1.59-141.24; P = 0.008). Therefore, the 14-bp polymorphism could be an important predictive factor for aGvHD following bone marrow transplantation.
引用
收藏
页码：284 / 288
页数：5
相关论文
共 50 条
  • [21] Serum TNFα levels in patients with acute graft-versus-host disease after bone marrow transplantation
    Huang, XJ
    Wan, J
    Lu, DP
    LEUKEMIA, 2001, 15 (07) : 1089 - 1091
  • [22] Predicting the severity of graft-versus-host disease from interleukin-10 levels after bone marrow transplantation
    H Takatsuka
    Y Takemoto
    T Okamoto
    Y Fujimori
    S Tamura
    H Wada
    M Okada
    S Yamada
    A Kanamaru
    E Kakishita
    Bone Marrow Transplantation, 1999, 24 : 1005 - 1007
  • [23] DIGESTIVE DISEASES OF GRAFT-VERSUS-HOST DISEASE IN BONE-MARROW TRANSPLANTATION, SOLID-ORGAN TRANSPLANTATION AND TRANSFUSION
    LI, V
    MOLINA, L
    MICHALLET, M
    HOSTEIN, J
    GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE, 1992, 16 (01): : 29 - 36
  • [24] Donor-recipient incompatibility at CD31-codon 563 is a major risk factor for acute graft-versus-host disease after allogeneic bone marrow transplantation from a human leucocyte antigen-matched donor
    Balduini, CL
    Frassoni, F
    Noris, P
    Klersy, C
    Iannone, AM
    Bacigalupo, A
    Giorgiani, G
    Di Pumpo, M
    Locatelli, F
    BRITISH JOURNAL OF HAEMATOLOGY, 2001, 114 (04) : 951 - 953
  • [25] Thrombotic microangiopathy following allogeneic bone marrow transplantation is associated with intensive graft-versus-host disease prophylaxis
    Paquette, RL
    Tran, L
    Landaw, EM
    BONE MARROW TRANSPLANTATION, 1998, 22 (04) : 351 - 357
  • [26] The prophylactic potential of fludarabine monophosphate in graft-versus-host disease after bone marrow transplantation in murine models
    Or, R
    Weiss, L
    Amir, G
    Tejman, S
    Polliack, A
    BONE MARROW TRANSPLANTATION, 2000, 25 (03) : 263 - 266
  • [27] The role of thalidomide in the treatment of refractory chronic graft-versus-host disease following bone marrow transplantation in children
    Rovelli, A
    Arrigo, C
    Nesi, F
    Balduzzi, A
    Nicolini, B
    Locasiulli, A
    Vassallo, E
    Miniero, R
    Uderzo, C
    BONE MARROW TRANSPLANTATION, 1998, 21 (06) : 577 - 581
  • [28] Apoptosis of ileal crypt epithelia after allogeneic bone marrow transplantation without graft-versus-host disease
    Kreft, Andreas
    Russo, Alexandra
    Lux, Steffi
    Waiz, Lioudmila
    Seidmann, Larissa
    Faber, Joerg
    Kirkpatrick, Charles J.
    CLINICAL CASE REPORTS, 2015, 3 (05): : 298 - 300
  • [29] Does oxypentifylline reduce the intensity of acute graft-versus-host disease following allogeneic bone marrow transplantation?
    Ghosh, K
    Hutchinson, RM
    HAEMATOLOGIA, 1996, 28 (01) : 45 - 51
  • [30] The prophylactic potential of fludarabine monophosphate in graft-versus-host disease after bone marrow transplantation in murine models
    R Or
    L Weiss
    G Amir
    S Tejman
    A Polliack
    Bone Marrow Transplantation, 2000, 25 : 263 - 266
12345